DUPILUMAB

dupilumab 300 mg/2 mL injection, 2 x 2 mL pen devices

DUPILUMAB (14965P)

dupilumab 300 mg/2 mL injection, 2 x 2 mL pen devices
14965P
Body System:
Manner of administration:Injection
Private
S100 HSD Private
Authority Required

Restriction

Indication: Uncontrolled severe asthma
Treatment phase: Initial treatment - Initial 1 (New patient; or Recommencement of treatment in a new treatment cycle following a break in PBS-subsidised biological medicine therapy)

Restriction

Indication: Uncontrolled severe asthma
Treatment phase: Initial treatment - Initial 2 (Change of treatment)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 2 # of repeats: 3 DPMQ: $1,658.74 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Dupixent